Akums Drugs and Pharmaceutical (AKUMS) — Net Asset Momentum
Akums Drugs and Pharmaceutical (AKUMS) recorded a net asset momentum of 8.7% as of March 2026, with net assets of Rs33.31 Billion INR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Akums Drugs and Pharmaceutical shareholders equity for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Akums Drugs and Pharmaceutical Net Asset Momentum (2022–2026)
This chart tracks Akums Drugs and Pharmaceutical's year-over-year net asset growth across 5 annual reporting periods from 2022 to 2026. The most recent momentum reading is +8.7%, with net assets of Rs33.31 Billion INR as of March 2026. For live market cap and overall valuation, see Akums Drugs and Pharmaceutical market capitalisation.
Annual Net Asset History for Akums Drugs and Pharmaceutical (2022–2026)
The table below shows the complete annual net asset history for Akums Drugs and Pharmaceutical from 2022 to 2026, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check Akums Drugs and Pharmaceutical tangible net worth ratio to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (INR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2026 | Rs33.31 Billion | Rs54.47 Billion | Rs21.16 Billion | ▲ +8.7% |
| 2025 | Rs30.64 Billion | Rs41.13 Billion | Rs10.50 Billion | ▲ +325.2% |
| 2024 | Rs7.20 Billion | Rs35.16 Billion | Rs27.96 Billion | ▼ -0.4% |
| 2023 | Rs7.23 Billion | Rs32.67 Billion | Rs25.43 Billion | ▲ +15.7% |
| 2022 | Rs6.25 Billion | Rs30.69 Billion | Rs24.44 Billion | — |